170 related articles for article (PubMed ID: 26908323)
21. Immunohistochemical expression of Notch1, Jagged1, NF-κB and MMP-9 in colorectal cancer patients and the relationship to clinicopathological parameters.
Zheng CG; Chen R; Xie JB; Liu CB; Jin Z; Jin C
Cancer Biomark; 2015; 15(6):889-97. PubMed ID: 26406415
[TBL] [Abstract][Full Text] [Related]
22. An analysis of the duplicate testing strategy of an Irish immunochemical faecal occult blood test colorectal cancer screening programme.
Kelley L; Swan N; Hughes DJ
Colorectal Dis; 2013 Sep; 15(9):e512-21. PubMed ID: 23746062
[TBL] [Abstract][Full Text] [Related]
23. A new fecal calprotectin test for colorectal neoplasia. Clinical results and comparison with previous method.
Johne B; Kronborg O; Tøn HI; Kristinsson J; Fuglerud P
Scand J Gastroenterol; 2001 Mar; 36(3):291-6. PubMed ID: 11305517
[TBL] [Abstract][Full Text] [Related]
24. [Faecal pyruvate kinase type M2--a valid screening parameter for colorectal cancer? Preliminary results from a multicenter comparative study].
Naumann M; Schaum B; Oremek GM; Hanisch E; Rösch W; Mössner J; Caspary WF; Stein J
Dtsch Med Wochenschr; 2004 Aug; 129(34-35):1806-7. PubMed ID: 15314744
[No Abstract] [Full Text] [Related]
25. A novel faecal
Liang JQ; Li T; Nakatsu G; Chen YX; Yau TO; Chu E; Wong S; Szeto CH; Ng SC; Chan FKL; Fang JY; Sung JJY; Yu J
Gut; 2020 Jul; 69(7):1248-1257. PubMed ID: 31776231
[TBL] [Abstract][Full Text] [Related]
26. Risk stratification and detection of new colorectal neoplasms after colorectal cancer screening with faecal occult blood test: experiences from a Danish screening cohort.
Bjerrum A; Milter MC; Andersen O; Fischer A; Lynge E
Eur J Gastroenterol Hepatol; 2015 Dec; 27(12):1433-7. PubMed ID: 26352132
[TBL] [Abstract][Full Text] [Related]
27. Colonoscopy findings in high-risk individuals compared to an average-risk control population.
Forsberg A; Kjellström L; Andreasson A; Jaramillo E; Rubio CA; Björck E; Agréus L; Talley NJ; Lindblom A
Scand J Gastroenterol; 2015 Jul; 50(7):866-74. PubMed ID: 25762374
[TBL] [Abstract][Full Text] [Related]
28. Faecal immunochemical test-based colorectal cancer screening programme SVIT in Slovenia: pilot phase.
Tepeš B; Stabuc B; Stefanovič M; Bračko M; Frkovič Grazio S; Novak Mlakar D; Maučec Zakotnik J
Eur J Cancer Prev; 2014 Jul; 23(4):235-9. PubMed ID: 24030444
[TBL] [Abstract][Full Text] [Related]
29. CA11-19: a tumor marker for the detection of colorectal cancer.
Overholt BF; Wheeler DJ; Jordan T; Fritsche HA
Gastrointest Endosc; 2016 Mar; 83(3):545-51. PubMed ID: 26318832
[TBL] [Abstract][Full Text] [Related]
30. Quantitative immunochemical fecal occult blood testing for colorectal adenoma detection: evaluation in the target population of screening and comparison with qualitative tests.
Haug U; Hundt S; Brenner H
Am J Gastroenterol; 2010 Mar; 105(3):682-90. PubMed ID: 19953091
[TBL] [Abstract][Full Text] [Related]
31. The association between the serum levels of matrix metalloproteinase 9 and colorectal cancer.
Rašić I; Rašić A; Akšamija G; Radović S; Šehović N
Med Glas (Zenica); 2017 Aug; 14(2):229-235. PubMed ID: 28644426
[TBL] [Abstract][Full Text] [Related]
32. [Effectiveness of screening colonoscopy in a community-based study].
Hüppe D; Hartmann H; Felten G; Kemen M; Tannapfel A; Gillessen A; Katalinic A
Z Gastroenterol; 2008 Feb; 46(2):193-200. PubMed ID: 18253898
[TBL] [Abstract][Full Text] [Related]
33. Randomised study of screening for colorectal cancer with faecal-occult-blood test.
Kronborg O; Fenger C; Olsen J; Jørgensen OD; Søndergaard O
Lancet; 1996 Nov; 348(9040):1467-71. PubMed ID: 8942774
[TBL] [Abstract][Full Text] [Related]
34. High-definition chromocolonoscopy vs. high-definition white light colonoscopy for average-risk colorectal cancer screening.
Kahi CJ; Anderson JC; Waxman I; Kessler WR; Imperiale TF; Li X; Rex DK
Am J Gastroenterol; 2010 Jun; 105(6):1301-7. PubMed ID: 20179689
[TBL] [Abstract][Full Text] [Related]
35. Equivalency of fecal immunochemical tests and colonoscopy in familial colorectal cancer screening.
Quintero E; Carrillo M; Gimeno-García AZ; Hernández-Guerra M; Nicolás-Pérez D; Alonso-Abreu I; Díez-Fuentes ML; Abraira V
Gastroenterology; 2014 Nov; 147(5):1021-30.e1; quiz e16-7. PubMed ID: 25127679
[TBL] [Abstract][Full Text] [Related]
36. Increased risk of colorectal neoplasia among family members of patients with colorectal cancer: a population-based study in Utah.
Samadder NJ; Curtin K; Tuohy TM; Rowe KG; Mineau GP; Smith KR; Pimentel R; Wong J; Boucher K; Burt RW
Gastroenterology; 2014 Oct; 147(4):814-821.e5; quiz e15-6. PubMed ID: 25042087
[TBL] [Abstract][Full Text] [Related]
37. Performance of immunochemical faecal occult blood test in colorectal cancer screening in average-risk population according to positivity threshold and number of samples.
Guittet L; Bouvier V; Mariotte N; Vallee JP; Levillain R; Tichet J; Launoy G
Int J Cancer; 2009 Sep; 125(5):1127-33. PubMed ID: 19431212
[TBL] [Abstract][Full Text] [Related]
38. Novel Circulating Tumor Cell Assay for Detection of Colorectal Adenomas and Cancer.
Tsai WS; You JF; Hung HY; Hsieh PS; Hsieh B; Lenz HJ; Idos G; Friedland S; Yi-Jiun Pan J; Shao HJ; Wu JC; Lai JM; Chang SE; Mei R; Watson D; Javey M; Nimgaonkar A
Clin Transl Gastroenterol; 2019 Oct; 10(10):e00088. PubMed ID: 31663904
[TBL] [Abstract][Full Text] [Related]
39. Elevated serum matrix metalloproteinase 9 (MMP-9) concentration predicts the presence of colorectal neoplasia in symptomatic patients.
Hurst NG; Stocken DD; Wilson S; Keh C; Wakelam MJ; Ismail T
Br J Cancer; 2007 Oct; 97(7):971-7. PubMed ID: 17912241
[TBL] [Abstract][Full Text] [Related]
40. Clusterin in stool: a new biomarker for colon cancer screening?
Pucci S; Bonanno E; Sesti F; Mazzarelli P; Mauriello A; Ricci F; Zoccai GB; Rulli F; Galatà G; Spagnoli LG
Am J Gastroenterol; 2009 Nov; 104(11):2807-15. PubMed ID: 19623170
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]